Registered number: 09177059
|
Alistair Morgan & Associates Limited
Financial statements
Information for filing with the registrar
30 June 2024
|
|
|
|
|
|
Alistair Morgan & Associates Limited
|
Balance sheet
At 30 June 2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Creditors: amounts falling due within one year
|
|
|
|
|
|
Net current (liabilities)/assets
|
|
|
|
|
|
Total assets less current liabilities
|
|
|
|
|
|
Creditors: amounts falling due after more than one year
|
|
|
|
|
|
Provisions for liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
Alistair Morgan & Associates Limited
|
Balance sheet (continued)
At 30 June 2024
The directors consider that the company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The company's financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.
The financial statements were approved and authorised for issue by the board and were signed on its behalf on 19 March 2025.
Company registered number: 09177059
The notes on pages 3 to 6 form part of these financial statements.
2
|
|
|
|
Alistair Morgan & Associates Limited
|
Notes to the financial statements
Year ended 30 June 2024
Alistair Morgan & Associates Limited ('the company') is a private company limited by shares, incorporated and domiciled in the United Kingdom and registered in England and Wales. The address of the registered office is St. Johns Surgery, Lake Road, Windermere, Cumbria, LA23 2EQ.
2.Accounting policies
|
|
Basis of preparation of financial statements
|
The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.
The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the company's accounting policies.
The following principal accounting policies have been applied:
The turnover in the profit and loss account represents NHS contract income, private fees and capitation schemes income receivable during the period.
Interest income is recognised in profit or loss using the effective interest method.
Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.
Amortisation is provided on the following bases:
Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.
3
|
|
|
|
Alistair Morgan & Associates Limited
|
Notes to the financial statements
Year ended 30 June 2024
2.Accounting policies (continued)
|
|
Tangible fixed assets (continued)
|
Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis.
Depreciation is provided on the following basis:
The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.
Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.
|
|
|
The average monthly number of employees, including the directors, during the year was 14 (2023: 12).
|
4
|
|
|
|
Alistair Morgan & Associates Limited
|
Notes to the financial statements
Year ended 30 June 2024
|
|
|
|
|
|
|
|
|
Amounts owed by group undertakings
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5
|
|
|
|
Alistair Morgan & Associates Limited
|
Notes to the financial statements
Year ended 30 June 2024
|
Creditors: amounts falling due within one year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts owed to group undertakings
|
|
|
|
|
|
|
|
Other taxation and social security
|
|
|
|
Obligations under finance lease and hire purchase contracts
|
|
|
|
|
|
|
|
Accruals and deferred income
|
|
|
|
|
|
|
|
|
|
|
|
Creditors: amounts falling due after more than one year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net obligations under finance leases and hire purchase contracts
|
|
|
|
|
|
|
|
|
|
|
|
Related party transactions
|
|
During the year, the company operated on normal commercial terms with Lakeland Medical Holdings Limited. The amount owed to Lakeland Medical Holdings Limited at 30 June 2024 was £31,819 (2023: £76,181 owed from Lakeland Medical Holdings Limited).
During the year, the company operated on normal commercial terms with Vitorino Limited. The amount owed to Vitorino Limited at 30 June 2024 was £18,652 (2023: £9,052).
During the year, the company operated on normal commercial terms with Cartmell Medical Services Limited. The amount owed to Cartmell Medical Services Limited at 30 June 2024 was £9,600 (2023: £4,800).
|
6
|